# Knee Injections for Obese Patients With Knee Arthritis

> **NCT06782529** · PHASE4 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 40 (estimated)

## Conditions studied

- Osteoarthritis of Knee

## Interventions

- **DRUG:** Triamcinolone Acetonide Low Dose
- **DRUG:** Triamcinolone Acetonide Standard Dose

## Key facts

- **NCT ID:** NCT06782529
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-24
- **Primary completion:** 2027-01-24
- **Final completion:** 2027-01-24
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06782529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06782529, "Knee Injections for Obese Patients With Knee Arthritis". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06782529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*